TXNRD1, thioredoxin reductase 1, 7296

N. diseases: 136; N. variants: 21
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C3669121
Disease: 11-Beta-hydroxylase deficiency
11-Beta-hydroxylase deficiency
0.010 GeneticVariation disease BEFREE Less frequent types of CAH are 11β-hydroxylase deficiency (up to 8% of cases), 17α-hydroxylase deficiency, 3β-hydroxysteroid dehydrogenase deficiency, P450 oxidoreductase deficiency and StAR deficiencies. 29543924 2018
CUI: C0023487
Disease: Acute Promyelocytic Leukemia
Acute Promyelocytic Leukemia
0.010 Biomarker disease BEFREE We report here that shikonin may interact with the cytosolic thioredoxin reductase (TrxR1), an important selenocysteine (Sec)-containing antioxidant enzyme with a C-terminal -Gly-Cys-Sec-Gly active site, to induce reactive oxygen species (ROS)-mediated apoptosis in human promyelocytic leukemia HL-60 cells. 24583460 2014
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.010 AlteredExpression group BEFREE In subgroup, lower serum TrxR1 activity patients had long OS both in adenocarcinoma (ADC) (17m vs. 8m, <i>p</i>=0.003) and squamous cell carcinoma (SCC) (13m vs. 11m, <i>p</i>=0.035). 29383158 2017
CUI: C0001430
Disease: Adenoma
Adenoma
0.310 Biomarker group CTD_human Consistent with the individual SNP results, we observed a significant overall association with adenoma risk for SEPP1 and TXNRD1 (global P = 0.02 and 0.008, respectively) but not for the four GPX genes. 18483336 2008
CUI: C0001430
Disease: Adenoma
Adenoma
0.310 GeneticVariation group BEFREE Consistent with the individual SNP results, we observed a significant overall association with adenoma risk for SEPP1 and TXNRD1 (global P = 0.02 and 0.008, respectively) but not for the four GPX genes. 18483336 2008
CUI: C0001430
Disease: Adenoma
Adenoma
0.310 GeneticVariation group LHGDN Consistent with the individual SNP results, we observed a significant overall association with adenoma risk for SEPP1 and TXNRD1 (global P = 0.02 and 0.008, respectively) but not for the four GPX genes. 18483336 2008
CUI: C1302401
Disease: Adenoma of large intestine
Adenoma of large intestine
0.010 GeneticVariation disease BEFREE Furthermore, we observed a significant 80% reduction for advanced colorectal adenoma risk for carriers of the variant allele at TXNRD1 IVS1-181C>G (OR, 0.20; 95% CI, 0.07-0.55; P trend = 0.004). 18483336 2008
CUI: C0205646
Disease: Adenoma, Basal Cell
Adenoma, Basal Cell
0.300 Biomarker disease CTD_human Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma. 18483336 2008
CUI: C0205648
Disease: Adenoma, Microcystic
Adenoma, Microcystic
0.300 Biomarker disease CTD_human Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma. 18483336 2008
CUI: C0205649
Disease: Adenoma, Monomorphic
Adenoma, Monomorphic
0.300 Biomarker disease CTD_human Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma. 18483336 2008
CUI: C0205651
Disease: Adenoma, Trabecular
Adenoma, Trabecular
0.300 Biomarker disease CTD_human Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma. 18483336 2008
CUI: C0220630
Disease: Adult Liver Carcinoma
Adult Liver Carcinoma
0.010 AlteredExpression disease BEFREE Statin treatment was associated with 45% lower expression and activity of TrxR1 in a rat model for liver cancer (p = 0.03). 22222370 2012
CUI: C0278877
Disease: Adult Meningioma
Adult Meningioma
0.010 Biomarker disease BEFREE The immunostaining intensity of TrxR1 increased significantly with meningioma grade (p < 0.001). 25592259 2015
CUI: C0036646
Disease: Age-related cataract
Age-related cataract
0.010 Biomarker disease BEFREE Here, we first compared the methylation levels of six essential antioxidant genes (GSTP1, NRF2, OGG1, TXN, TXNRD1 and TXNRD2) between highly myopic cataract (HMC) and age-related cataract (ARC) lens epithelial samples via Sequenom MassARRAY. 30172102 2018
CUI: C0002395
Disease: Alzheimer's Disease
Alzheimer's Disease
0.020 Biomarker disease BEFREE Enrichment analyses showed that NADH:Ubiquinone Oxidoreductase Core Subunit V2 (<i>NDUFV2</i>) was involved in several neurological diseases, including oxidative phosphorylation, Alzheimer's disease, Parkinson's disease and Huntington's disease. 28413470 2017
CUI: C0002395
Disease: Alzheimer's Disease
Alzheimer's Disease
0.020 Biomarker disease BEFREE Geographical Distribution and Diversity of Gut Microbial NADH:Ubiquinone Oxidoreductase Sequence Associated with Alzheimer's Disease. 29376868 2018
CUI: C1862939
Disease: AMYOTROPHIC LATERAL SCLEROSIS 1
AMYOTROPHIC LATERAL SCLEROSIS 1
0.010 GeneticVariation disease BEFREE The TXNRD1 haplotypes were reconstructed using the EH and PHASE 2.1 programs and also showed an association with FALS. 18996185 2009
Amyotrophic Lateral Sclerosis, Familial
0.010 GeneticVariation disease BEFREE Thioredoxin reductase 1 haplotypes modify familial amyotrophic lateral sclerosis onset. 18996185 2009
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.010 Biomarker disease BEFREE Selenoproteins of particular relevance to atherosclerosis are glutathione peroxidases, thioredoxin reductase 1, selenoprotein P, selenoprotein S. The present review is focusing on the existing evidence that supports the concept that optimal selenium intake can prevent atherosclerosis. 28009916 2017
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.010 Biomarker disease BEFREE Selenoproteins of particular relevance to atherosclerosis are glutathione peroxidases, thioredoxin reductase 1, selenoprotein P, selenoprotein S. The present review is focusing on the existing evidence that supports the concept that optimal selenium intake can prevent atherosclerosis. 28009916 2017
CUI: C0236018
Disease: Aura
Aura
0.300 Biomarker phenotype CTD_human Changes in the expression of selenoproteins in mesial temporal lobe epilepsy patients. 19499324 2009
CUI: C0751111
Disease: Awakening Epilepsy
Awakening Epilepsy
0.300 Biomarker disease CTD_human Changes in the expression of selenoproteins in mesial temporal lobe epilepsy patients. 19499324 2009
CUI: C0079731
Disease: B-Cell Lymphomas
B-Cell Lymphomas
0.020 AlteredExpression group BEFREE However, down regulation of anti-apoptotic markers B-cell lymphoma 2 (Bcl2) and anti-oxidant thioredoxin reductase 1 (TXNRD1) expression were observed. 31446057 2019
CUI: C0079731
Disease: B-Cell Lymphomas
B-Cell Lymphomas
0.020 Biomarker group BEFREE Compared with control group, the decreased (P < 0.05) activities of glutathione peroxidase (GSH-Px) and cytoplasmic thioredoxin reductase (TrxR1) as well as contents of selenoprotein P (SelP), total protein (TP), and B-cell lymphoma-2 in serum and tissues were observed in high F group. 29897571 2018
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.070 GeneticVariation disease BEFREE Four SNPs (GPX3 rs2070593, rsGPX4 rs2074451, SELS rs9874, and TXNRD1 rs17202060) significantly interacted with dietary oxidative balance score after adjustment for multiple comparisons to alter breast cancer risk. 24278290 2013